# Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors

> **NCT01138033** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 74 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** GSK2256098

## Key facts

- **NCT ID:** NCT01138033
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-27
- **Primary completion:** 2015-12-21
- **Final completion:** 2015-12-21
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01138033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01138033, "Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01138033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*